Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Maj 2024

Biotek-snakken — Maj 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
67 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #39

    Godmorgen...

    1 Reply Last reply
    0
    • L Offline
      L Offline
      LP90
      wrote on sidst redigeret af
      #40

      Morning 🙂

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #41

        Godmorgen...

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #42

          Godmorgen 🙂

          1 Reply Last reply
          0
          • D Offline
            D Offline
            DECIDE
            wrote on sidst redigeret af
            #43

            Nanexa ser interessant ud.

            1 Reply Last reply
            0
            • D Offline
              D Offline
              DECIDE
              wrote on sidst redigeret af
              #44

              Deres PharmaShell teknologi kunne være godt bud på Long acting injectables for en række lægemidler. Har projekt med liraglutid. Desuden muligt partnerskab med Novo Nordisk, mon ikke glp1/sema, men undisclosed Her ligger upside især og Novo skal snart beslutte, om de vil indgå licensaftale. Lav marketcap., høj
              risiko, stor upside.

              1 Reply Last reply
              0
              • D Offline
                D Offline
                DECIDE
                wrote on sidst redigeret af
                #45

                Xspray en en anden jeg har øje til. Dasynoc har PDUFA dato 31. juli i år. Høj
                risiko også, men kan blive stort.

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  DECIDE
                  wrote on sidst redigeret af
                  #46

                  Som en sidste vil jeg nævne BioInvent. Har efterhånden 5 molekyler i klinikken, og der venter et meget spændende år med mange data, særlig på
                  BI1808 og BI1206.

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    DECIDE
                    wrote on sidst redigeret af
                    #47

                    Hører gerne fra andre om de tre selskaber og jeres vurdering.

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #48

                      Calliditas Therapeutics - Calliditas Q1 report, January – March 2024:

                      Link Preview Image
                      Calliditas Therapeutics AB

                      Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

                      favicon

                      Calliditas Therapeutics AB (www.calliditas.se)

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #49

                        Target market expansion following full approval in the US

                        Net sales amounted to SEK 295.5 million, of which TARPEYO® net sales amounted to SEK 278.3 million, for the three months ended March 31, 2024. For the three months ended March 31, 2023, net sales amounted to SEK 191.4 million, of which TARPEYO net sales amounted to SEK 185.7 million.

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #50

                          “In Q1 we generated another record quarter in terms of demand with 705 enrollments and 354 new prescribers. We are very excited over this positive trend, and we continue to see strong demand in Q2.” – CEO Renée Aguiar-Lucander.

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #51

                            Calliditas Q1: A powerful Tarpeyo launch momentum

                            Just a moment...

                            favicon

                            (www.redeye.se)

                            (Redeye)

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #52

                              STENOCARE lancerer næste generation af medicinsk cannabisolie i Australien - seks måneder før planlagt https://proinvestor.com/boards/120588

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #53

                                Calliditas Q1: A powerful Tarpeyo launch momentum

                                RESEARCH UPDATE 2024-05-24

                                Just a moment...

                                favicon

                                (www.redeye.se)

                                (Redeye)

                                "Base Case: SEK 285 (270) per share"

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #54

                                  2 Biotech Stocks to Buy in May https://proinvestor.com/investornyt/1164512/2-biotech-stocks-to-buy-in-may

                                  1 Reply Last reply
                                  0
                                  • D Offline
                                    D Offline
                                    DECIDE
                                    wrote on sidst redigeret af
                                    #55

                                    Troldmanden, sætter pris på dine kommentarer. Tag et kig på Nanexa ved lejlighed, dels deres liraglutid-projekt, dels deres partnerskab med NN. Lyt f.eks. til deres kapitalmarkedsdag, der ligger på hjemmesiden.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #56

                                      Dagens aktie er AbCellera Biologics Inc.

                                      AbCellera Biologics bygger en motor til opdagelse og udvikling af antistoflægemidler.
                                      Antistoffer er proteiner produceret af immunsystemet, som genkender og eliminerer mål som vira og bakterier. https://proinvestor.com/boards/120628

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #57

                                        Asahi Kasei lägger rekommenderat kontantbud på Calliditas värt 208 kronor per aktie - premie på 83 procent.

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #58

                                          Solgt og helt ude ...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper